D. E. Shaw & Co., Inc. Poseida Therapeutics, Inc. Transaction History

D. E. Shaw & Co., Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.66 - $3.4 $97,036 - $198,750	-58,456 Reduced 68.27%	27,173 $47,000
Q1 2023 May 15, 2023	SELL	$3.08 - $8.73 $780,755 - $2.21 Million	-253,492 Reduced 74.75%	85,629 $263,000
Q4 2022 Feb 14, 2023	BUY	$3.33 - $6.38 $476,979 - $913,852	143,237 Added 73.12%	339,121 $1.8 Million
Q3 2022 Nov 14, 2022	BUY	$2.43 - $4.51 $475,998 - $883,436	195,884 New	195,884 $691,000

103

38.7M

377K

22.2K

Ticker PSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,775,600
Market Cap $815M
Description
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.